VRCA
NASDAQ · Pharmaceuticals
Verrica Pharmaceuticals Inc
$4.50
-0.35 (-7.22%)
Open$4.88
Previous Close$4.85
Day High$5.20
Day Low$4.25
52W High$9.82
52W Low$3.28
Volume—
Avg Volume154.9K
Market Cap99.78M
P/E Ratio—
EPS$-1.61
SectorPharmaceuticals
Analyst Ratings
Strong Buy
11 analysts
Price Target
+113.1% upside
Current
$4.50
$4.50
Target
$9.59
$9.59
$7.88
$9.59 avg
$13.36
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 58.36M | 36.95M | 35.73M |
| Net Income | -29,341,405 | -16,719,807 | 6.74M |
| Profit Margin | -50.3% | -47.8% | 18.9% |
| EBITDA | -21,712,045 | -13,059,669 | 12.85M |
| Free Cash Flow | — | — | 8.80M |
| Rev Growth | +57.9% | +57.9% | +7.9% |
| Debt/Equity | 0.04 | 0.04 | 0.56 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |